These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28342897)

  • 1. Dose-response effect of acute phencyclidine on functional connectivity and dopamine levels, and their association with schizophrenia-like symptom classes in rat.
    Paasonen J; Salo RA; Ihalainen J; Leikas JV; Savolainen K; Lehtonen M; Forsberg MM; Gröhn O
    Neuropharmacology; 2017 Jun; 119():15-25. PubMed ID: 28342897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity.
    Kehr J; Yoshitake T; Ichinose F; Yoshitake S; Kiss B; Gyertyán I; Adham N
    Psychopharmacology (Berl); 2018 May; 235(5):1593-1607. PubMed ID: 29637288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dopamine D₃-preferring D₂/D₃ dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia.
    Watson DJG; King MV; Gyertyán I; Kiss B; Adham N; Fone KCF
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):208-224. PubMed ID: 26723167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.
    Spano MS; Fattore L; Cadeddu F; Fratta W; Fadda P
    Psychopharmacology (Berl); 2013 Feb; 225(3):531-42. PubMed ID: 22903392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-anaesthetic interaction in phMRI: the case of the psychotomimetic agent phencyclidine.
    Gozzi A; Schwarz A; Crestan V; Bifone A
    Magn Reson Imaging; 2008 Sep; 26(7):999-1006. PubMed ID: 18486387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology.
    Neill JC; Grayson B; Kiss B; Gyertyán I; Ferguson P; Adham N
    Eur Neuropsychopharmacol; 2016 Jan; 26(1):3-14. PubMed ID: 26655189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal phencyclidine and social isolation in the rat: effects of clozapine on locomotor activity, social recognition, prepulse inhibition, and executive functions deficits.
    Hamieh AM; Babin D; Sablé E; Hernier AM; Castagné V
    Psychopharmacology (Berl); 2021 Feb; 238(2):517-528. PubMed ID: 33169202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A schizophrenia rat model induced by early postnatal phencyclidine treatment and characterized by Magnetic Resonance Imaging.
    Broberg BV; Madsen KH; Plath N; Olsen CK; Glenthøj BY; Paulson OB; Bjelke B; Søgaard LV
    Behav Brain Res; 2013 Aug; 250():1-8. PubMed ID: 23644161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of phencyclidine-induced spatial learning and memory deficits and reversal by sertindole and risperidone between Lister Hooded and Wistar rats.
    Ihalainen J; Savolainen K; Tanila H; Forsberg MM
    Behav Brain Res; 2016 May; 305():140-7. PubMed ID: 26940605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model.
    Wang D; Noda Y; Zhou Y; Nitta A; Furukawa H; Nabeshima T
    Neuropharmacology; 2007 Mar; 52(4):1179-87. PubMed ID: 17313962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the long-term effect of subchronic phencyclidine-treatment on novel object recognition and the association between the gut microbiota and behavior in the animal model of schizophrenia.
    Pyndt Jørgensen B; Krych L; Pedersen TB; Plath N; Redrobe JP; Hansen AK; Nielsen DS; Pedersen CS; Larsen C; Sørensen DB
    Physiol Behav; 2015 Mar; 141():32-9. PubMed ID: 25545766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels.
    Metaxas A; Willems R; Kooijman EJ; Renjaän VA; Klein PJ; Windhorst AD; Donck LV; Leysen JE; Berckel BN
    J Neurosci Res; 2014 Nov; 92(11):1599-607. PubMed ID: 24953757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex.
    Abekawa T; Ito K; Koyama T
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):177-93. PubMed ID: 17103144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol attenuates the cognitive deficits in the novel object recognition task induced by sub-chronic phencyclidine in ovariectomized rats.
    Roseman AS; McGregor C; Thornton JE
    Behav Brain Res; 2012 Jul; 233(1):105-12. PubMed ID: 22561127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCP-induced deficits in murine nest building activity: employment of an ethological rodent behavior to mimic negative-like symptoms of schizophrenia.
    Pedersen CS; Sørensen DB; Parachikova AI; Plath N
    Behav Brain Res; 2014 Oct; 273():63-72. PubMed ID: 25064467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A primate model of schizophrenia using chronic PCP treatment.
    Mao CV; Hori E; Maior RS; Ono T; Nishijo H
    Rev Neurosci; 2008; 19(2-3):83-9. PubMed ID: 18751516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
    Balla A; Sershen H; Serra M; Koneru R; Javitt DC
    Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.
    Pedersen CS; Goetghebeur P; Dias R
    J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia.
    Thomson S; Dyck B; Daya R; Ho J; Bernardo A; Tian Y; Mishra RK
    Synapse; 2019 May; 73(5):e22084. PubMed ID: 30582667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand.
    Guo Y; Zhang H; Chen X; Cai W; Cheng J; Yang Y; Jin G; Zhen X
    Schizophr Res; 2009 Nov; 115(1):41-9. PubMed ID: 19744833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.